Here are what the editors at HealthDay consider to be the most important developments in Cardiology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Some Weather Conditions Linked to Myocardial Infarction Risk
WEDNESDAY, Oct. 31, 2018 (HealthDay News) — Certain weather conditions are associated with an increased risk for myocardial infarction (MI), according to a study published online Oct. 24 in JAMA Cardiology.
Link Between Statins, Non-CVD Outcomes Lacks Evidence
WEDNESDAY, Oct. 31, 2018 (HealthDay News) — There is a lack of convincing evidence for an association between statin use and non-cardiovascular disease (CVD) outcomes, according to a review published in the Oct. 16 issue of the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Discharge Day Does Not Impact Readmission After Cardiac Sx
WEDNESDAY, Oct. 31, 2018 (HealthDay News) — For cardiac surgical patients, the likelihood of readmission has no association with day of discharge, according to a study published online Oct. 11 in the Annals of Thoracic Surgery.
Abstract/Full Text (subscription or payment may be required)
Few Smokers With PAD Receive Adequate Cessation Support
TUESDAY, Oct. 30, 2018 (HealthDay News) — More than one-third of patients with peripheral artery disease (PAD) are active smokers, yet few of them receive evidence-based smoking cessation interventions, according to a study published in the Oct. 16 issue of the Journal of the American Heart Association.
Abstract/Full Text (subscription or payment may be required)
AMA Announces Initiative to Reinvent Physician Training
TUESDAY, Oct. 30, 2018 (HealthDay News) — The American Medical Association (AMA) today announced a new $15 million competitive grant initiative, the “Reimagining Residency” initiative, aimed at improving residency training.
Pilot Studies May Shed Light on How to Treat Lymphedema
TUESDAY, Oct. 30, 2018 (HealthDay News) — Treatment with ketoprofen may improve the skin biology in lymphedema, with improvements noted in histopathology and skin thickness, according to a study published online Oct. 18 in JCI Insight.
Angiotensin-Converting Enzyme Inhibitors May Up Lung CA Risk
TUESDAY, Oct. 30, 2018 (HealthDay News) — The use of angiotensin-converting enzyme inhibitors (ACEIs) is associated with an increased risk for lung cancer compared with angiotensin receptor blockers, according to a study published online Oct. 24 in the BMJ.
Accepting Increased-Risk Donor Heart Tied to Higher Survival
TUESDAY, Oct. 30, 2018 (HealthDay News) — Acceptance of a heart from an increased-risk donor (IRD) is associated with a significant survival benefit, according to a research letter published in the November issue of the Journal of the American College of Cardiology.
Poor Mental Health Tied to Premature Heart Disease 
Autism Tied to Higher Risk for Developing Cardiometabolic Disease 
Cardiovascular Hospitalization Increased After Sepsis Hospitalization 
Risk for Cardiovascular Disease Increased for Patients With Celiac Disease 
Non-Celiac Gluten/Wheat Sensitivity Self-Reported by 10.3 Percent 
Gluten-Stimulated Interleukin-2 Secretion Useful for Diagnosing Celiac Disease 
Gluten-Free Diet for Celiac Disease Increases Arsenic Exposure in Children 
Machine Learning Model Accurately Diagnoses Celiac Disease 
